Summary
Cell cross-contamination in cell cultures is a common problem during cell culturing and use. Contamination invalidates research results, compromises the comparison of results between laboratories, reduces reproducibility required in industrial production of cell lines, and may lead to unusable therapeutic products. The problem can be solved by increasing the awareness of its seriousness and by introducing regular quality control of cell cross-contamination in every laboratory where cells are grown and used.
Similar content being viewed by others
References
American Type Culture Collection catalog. Registry of animal cell lines certified by the cell culture collection committee. 1st ed. Rockville, MD: ATCC; 1964.
American Type Culture Collection of cell lines and hybridomas. Hay, R.; Caputo, J.; Chen, T., et al., eds. Rockville, MD: ATCC; 1994.
Appelbaum, F. Hematological disease. Acute leukemia. In: Wyngaarden, J.; Smith, L. H.; Bennett, J. C., eds. Cecil’s textbook of medicine. Philadelphia, PA: W. B. Saunders Co.; 1992:946–1947.
Benedetti, A.; Pytel, B.; Baglioni, C. Loss of 2,5, oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infection. Proc. Natl. Acad. Sci. 84:658–662; 1987.
Benedetti, A.; Pytel, B.; Baglioni, C. Retraction. Proc. Natl. Acad. Sci. 84:6740; 1987.
Brand, K. G.; Syverton, T. J. Immunology of cultivated mammalian cells. Species specificity determined by hemagglutination. J. Natl. Cancer Inst. 24:1007–1009; 1960.
Brunko, P.; Sauer, F. EEC legislation of medicinal products of biological origin. Dev. Biol. Stand. 75:21–25; 1991.
Chen, T. R. Reevaluation of HeLa, HeLa S3 and Hep-2 karyotypes. Cytogenet. Cell Genet. 48:19–24; 1988.
Christiansen, B.; Hansen, C.; Kieler, J., et al. Identity of non-malignant human uroepithelial cell lines classified as transformation grade I (TgrI) and II (TgrII). Anticancer Res. 13:2187–2192; 1993.
Clonetics. Normal human cell systems catalog. San Diego, CA; 1995–1996.
Committee for proprietary medicinal products. Ad hock working party on biotechnology/pharmacy (CPMP), 1987. Guidelines on the production and quality control of medicinal products derived by recombinant DNA technology. TIB Tech. 5:G1–3.
Committee for proprietary medicinal products. Ad hock working party on biotechnology/pharmacy (CPMP), 1988. Guidelines in the production and quality control of monoclonal antibodies of murine origin intended for use in man. TIB Tech. G5–8.
Coons, A. H.; Kaplan, M. M. Localization of antigens in tissue cells. Improvement in methods for detection of antigen by means of fluorescent antibody. J. Exp. Med. 91:1–13; 1950.
Dickinson, J. L.; Antalis, T. M. Response to letter to the editor. Leukemia 7:2079; 1993.
Drexel, H. G.; Hane, B.; Hu, Z., et al. HeLa cross-contamination of a leukemia cell line. Leukemia 12:2077–2078; 1993.
Embleton, M.; Gorochov, G.; Jones, P. T. In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells. Nucleic Acids Res. 20:3831–3837; 1992.
Ferrone, S.; Pellegrino, M. A.; Reisfeld, R. A. A rapid method for direct HL-A typing of cultured lymphoid cells. J. Immunol. 107:613–615; 1971.
Fogh, J. Contamination in tissue culture. New York: New York Academy Press; 1973.
Franks, D.; Daniel, M.; Gurner, B. V., et al. Variation in the forssman antigen in cell cultures. Exp. Cell Res. 36:310–324; 1963.
Freshney, R. I. Culture of animal cells. New York: John Wiley & Sons; 1994:243–252.
Gartler, S. M. Genetic markers as tracers in cell culture. Natl. Cancer Inst. Monogr. 26:167–195; 1967.
Gartler, S. M. Apparent HeLa cell contamination of human heteroploid cell lines. Nature 217:750–751; 1968.
Gignac, S. M.; Steube, K.; Schleithoff, L., et al. Multiparameter approach in the identification of cross-contaminated leukemia cell lines. Leuk. & Lymphoma 10:359–368; 1993.
Gilbert, D. A.; Reid, Y.; Gail, M., et al. Application of DNA fingerprints for cell line individualization. Am. J. Hum. Genet. 47:499–514; 1990.
Gold, M. A. Conspiracy of cells: one women legacy and the medical scandal it causes. Albany, NY: State University of NY Press; 1986.
Grachev, V. P. Viral safety of biological products in WHO policy. Dev. Biol. Stand. 75:241–246; 1991.
Hampe, J.; Nurnberg, P.; Epplen, C., et al. Oligonucleotide fingerprinting as a means to identify and survey long term cultured B cell hybridomas and T cell lines. Hum. Antib. Hybrid. 3:186; 1992.
Harris, H. Enzyme polymorphism in man. Proc. R. Soc. Lond. Ser. Biol. Sci. 164:298–301; 1966.
Harris, N. L.; Gang, D. L.; Quay, S. C., et al. Contamination of Hodgkin’s disease cell cultures. Nature 289:228–230; 1981.
Hay, R. J. Operator-induced contamination in cell culture systems. Dev. Biol. Stand. 75:193–204; 1991.
Hay, R. J. Methods for authenticating cell lines. Dev. Biol. Stand. 76:25–37; 1992.
Hay, R. J.; Caputo, J.; Macy, M. L. ATCC quality control methods for cell lines. Rockville, MD: ATCC; 1992:49–79.
Hay, R. J.; Reid, Y. A.; McClintock, P. R., et al. Cell banks and their role in cancer research. J. Cell. Biochem. Suppl. 24:107–130; 1996.
Honma, M.; Kataoka, E.; Ohnishi, K., et al. A new DNA profiling system for cell clone identification for use in cell banks in Japan. In Vitro Cell. Dev. Biol. 28A:24–28; 1992.
Horaud, F. Absence of viral sequences in the WHO-Vero cell bank. A collaborative study. Dev. Biol. Stand. 76:43–46; 1992.
Hsu, T. C.; Benirschke, A. An atlas of mammalian chromosomes. New York: Springer-Verlag; 1967–1975.
Hukku, B.; Halton, D.; Mally, M., et al. Cell characterization by use of multiple genetic markers. In: Acton, R. T.; Lynn, D. J., eds. Eukaryotic cell cultures. New York: Plenum Press; 1984:13–31.
Innovative Chemistry, Inc., Marshfield, MA 02050.
International Workshop on Current Issues—continuous cell lines. Dev. Biol. Stand. 76:3–37; 1991.
Jeffreys, A. J.; Wilson, V.; Thein, S. L. Hypervariable minisatellite regions of human DNA. Nature 314:67–73; 1985a.
Jeffreys, A. J.; Wilson, V.; Thein, S. L. Invalid species “fingerprints” of human DNA. Nature 316:76–79; 1985b.
Kawamura, A. Fluorescent antibody techniques and their application. Tokyo, Japan: Tokyo University Press; 1969.
Kozak, R. W. Introduction to the issues: recently developed methods for characterizing cell lines. Dev. Biol. Stand. 76:21–24; 1992.
King, B.; Lichtenstein, A.; Berenson, J., et al. Polymerase chain reaction-based microsatellite typing assay used for tumor cell line identification. Am. J. Pathol. 144:486–491; 1994.
Lavappa, K. S. Survey of ATTC stocks of human cell lines for HeLa contamination. In Vitro 14:469–475; 1978.
Leibovitz, A.; Wright, S.; Pathak, M., et al. Detection and analysis of G6PD phenotype B cell line contamination. J. Natl. Cancer Inst. 63:635; 1979.
Lichter, P.; Chang Tang, C.; Call, K. High resolution mapping of human chromosomes by in situ hybridization with cosmid clones. Science 274:64–69; 1990.
Lukens, J. Classification and differentiation of acute leukemias. In: Lee, R.; Bithell, T.; Foerster, J., et al., eds. Wintrobe’s clinical hematology. Philadelphia, PA: Lea & Febiger; 1993: 1873–1887.
Macville, M.; Zimonjic, D.; Popesku, N., et al. Spectral karyotyping of cervical carcinoma cell lines. J. Histochem. Cytochem. 44:782; 1996.
Macy, M. L. Identification of cell line species by isoenzyme analysis. TCA Man. 4:833–3; 1978.
Magrath, D. I. Safety of vaccines produced in continuous cell lines. Dev. Biol. Stand. 75:17–20; 1991.
Mann, D.; O’Brien, S.; Gilbert, D., et al. Origin of the HIV-susceptible human CD4+ cell line H9. Aids Res. Hum. Retroviruses 5:253–255; 1989.
Markovic, O. Kinetics of peroxidase activity in normal polymorphonuclear leukocytes. University in Belgrade, Yugoslovia; 1977a. Doctorate Thesis.
Markovic, O. Cell culture purity assessment based on classic cytochemical principles. J. Histochem. Cytochem. 44:789; 1996a.
Markovic, O. New application of image analysis based cytochemistry and immunocytochemistry in cell cultures. In Vitro Cell. Dev. Biol. 32A:58; 1996b.
Markovic, O.; Hay, R. J.; Steenbergen, K. Rapid screening and detection of minimal cell-cross contamination in cell cultures. J. Histochem. Cytochem. 44:75–76; 1996c.
Markovic, N.; Lipkin, L.; Markovic, O., et al. Device for quantitative cytochemistry: a computerized microdensitometer grain counter. J. Histochem. Cytochem. 26:792–802; 1978.
Markovic, O.; Markovic, N.; Rakic, L. J. Quantitative cytochemistry of enzymes. Belgrade, Yugoslavia: Univ Press; 1986a.
Markovic, N.; Markovic, O. Esterases inside blasts and neutrophils indicate prognosis of acute leukemia. Clin. Res. 36:414; 1988.
Markovic, O.; Markovic, N. Cytochemistry and immunocytochemistry in the classification of bone marrow and blood cells and in the diagnosis of hematological disorders. In: Ogawa, K.; Barka, T., eds. Electron microscopic cytochemistry and immunocytochemistry in biomedicine. Boca Raton, FL: CRC Press; 1992:611–638.
Markovic, N.; Markovic, O.; Markovic, S. Image processing assisted measurement of intracellular effect of enzyme targeting drugs. Cell Vision 2:71–78; 1995.
Markovic, N.; Markovic, O.; Roberts, J., et al. A new assay for intracellular measurement of inosine monophosphate dehydrogenase, a guide for better selection of patients for enzyme-targeted chemotherapy. J. Histochem. Cytochem. 40:895–902; 1992b.
Markovic, O.; Shulman, N. R. Megakaryocyte maturation indicated by methanol inhibition of acid phosphatase shared by megakaryocytes and platelets. Blood 50:905–913; 1977b.
Markovic, O.; Young, D.; Markovic, N. Enzyme kinetics in single cells. Concept and model. Clin. Chem. 23:1472–1475; 1977c.
Matsuba, I.; Lernmark, A.; Madsen, O., et al. Gene probes to detect cross-culture contamination in hormone producing cell lines. In Vitro Cell. Dev. Biol. 24:1970–1975; 1988.
McCulloch, E. A.; Parker, R. C. In: Begg, R. W., ed. Canadian cancer conference. Vol. 2. New York: Academic Press; 1957.
McGarrity, G. J. Detection of mycoplasma infection in cell culture. Adv. Cell Cult. 2:99–131; 1982.
Miele, M.; Bonatti Menickini, P. The fluorescence of amplified regions alters the stability of chromosomes in drug resistance Chinese hamster cells. Mutat. Res. 219:171–178; 1989.
Morita, T.; Shinohora, N.; Honma, M., et al. Establishment and characterization of a new cell line from a bladder cancer. Urol. Res. 23:143–149; 1995.
Nelson-Rees, W. A. Inter and intraspecies contamination of human breast tumor cell line specificity. Original and natural history of cell lines. Prog. Clin. Biol. Res. 26:25; 1978.
Nelson-Rees, W. A. Double minutes in human carcinoma cell lines, with special reference to breast tumors. J. Natl. Cancer Inst. 63:537; 1979.
Nelson-Rees, W. A.; Daniels, D.; Flandermeyer, R. R. Cross contamination of cells in cell culture. Science 212:446–452; 1981.
Nelson-Rees, W. A.; Flandermeyer, R. R. HeLa cultures defined. Science 191:96–97; 1976.
Nelson-Rees, W. A.; Flandermeyer, R. R. Inter- and intraspecies contamination of human breast tumor cell lines HBC and Br Ca5 and other cell cultures. Science 195:1343–1344; 1977.
Nelson-Rees, W. A.; Flandermeyer, R. R.; Daniels, D. T-1 cells are HeLa and not from normal human kidney origin. Science 209:719–720; 1980.
Nelson-Rees, W. A.; Flandermeyer, R. R.; Hawthorne, P. K. Banded marker chromosomes as indicators of intraspecies cellular contamination. Science 184:1093–1096; 1974.
Nicols, E. A.; Ruddle, F. H. Comparative sensitivity of electrophoretic assays for human enzymes. Biochem. Genet. 17:127–132; 1979.
Nuovo, G. Keys to successful in situ PCR. J. Histochem. Cytochem. 44:781; 1966.
O’Brien, S. J.; Kleiner, G.; Olsen, R., et al. Enzyme polymorphism as genetic signatures in human cell cultures. Science 195:1345–1348; 1977.
O’Brien, S. J.; Shannon, J. E.; Gail, M. H. Molecular approach to the identification and individualization of human and animal cells in culture: isozyme and allozyme genetic structure. In Vitro 16:119–135; 1980.
Office of Biologics Research Review (OBRR). Points to consider in the characterization of cell lines used to produce biologicals. Bethesda, MD: FDA; 1987.
Peterson, W. D., Jr. Biochemical identification and standards. Natl. Cancer Inst. Monogr. 29:55; 1968.
Peterson, W. D., Jr.; Stulberg, C. S.; Swanborg, N. K., et al. G6PD isoenzymes in human cell cultures determined by sucrose agar gel and cellulose acetate zymograms. Proc. Soc. Exp. Biol. Med. 128:772–776; 1968.
Pearson, J. Changing issues of quality control: diploid and non-diploid cell lines. Dev. Biol. Stand. 76:13–17; 1992.
Petricciani, J. C. Regulatory philosophy and acceptability of cells for the modulation of biologicals. Dev. Biol. Stand. 75:9–15; 1991.
Petricciani, J. C. Cell line issue: historical and future prospective. Dev. Biol. Stand. 76:5–11; 1992.
Quinnan, G. J. Workshop introduction and overview. International Workshop on current issues—continuous cell lines. Dev. Biol. Stand. 76:3–4; 1992.
Raap, T. Sensitive and high resolution fluorescent in situ hybridization. J. Histochem. Cytochem. 44:781; 1996.
Reid, Y. A.; Gilbert, D. A.; O’Brien, S. J. The use of DNA hypervariable probes for human cells identification. ATCC Newsletter 10:1–3; 1990.
Reid, Y. A.; O’Neill, K.; Chen, T. R., et al. Cell cross-contamination of U-937. J. Leukocyte Biol. 57:804; 1995.
Satoh, M.; Takeuchi, M. Cross-contamination of cell lines as revealed by DNA fingerprinting in the IFO animal cell bank. IFO Res. Commun. 16:18–23; 1993.
Schmidt, B. F.; Chao, J.; Zhu, Z., et al. Signal amplification in the detection of single copy DNA and RNA by enzyme-catalyzed deposition (CARD) of the novel fluorescent reporter substrate, Cy 3.29-tyramide. J. Histochem. Cytochem. 44:781; 1996.
Shimada, Y.; Imamura, M.; Wagata, T. Characterisation of 21 newly established esophageal cancer cell lines. Cancer 69:277–284; 1992.
Siciliano, M.; Barker, P. E.; Cailleau, R. Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker. Cancer Res. 39:919–922; 1979.
Simpson, W. F.; Stulberg, C. S. Species identification of animal cell strains by immunofluorescence. Nature 189:616–617; 1963.
Stacey, G. N.; Bolton, B.; Doyle, A. The quality control of cell banks using DNA fingerprinting. Experientia (Suppl.) 58:361–370; 1991.
Stacey, G. N.; Bolton, B.; Doyle, A. The DNA fingerprinting, a valuable new technique for the characterization of cell lines. Cytotechnology 9:211–216; 1992a.
Stacey, G. N.; Bolton, B.; Morgan, D., et al. Multilocus DNA fingerprint analysis of cell banks: stability studies and culture identification in human B-lymphoblastoid and mammalian cell stocks. Cytotechnology 8:13–20; 1992b.
Steube, K. G.; Grunicke, D.; Drexler, H. Isoenzyme analysis as a rapid method for the examination of the species identity of cell cultures. In Vitro Cell. Dev. Biol. 31:115–119; 1995.
Stevenson, R. Development of cell banking in the US 1960–1985: a strategic approach to quality control. Adv. Cell Cult. 51:267–288; 1987.
Stulberg, C. S. Extrinsic cell contamination of tissue cultures. In: Fogh, J., ed. Contamination in tissue culture. New York: Academic Press; 1973:1–27.
Stulberg, C. S.; Peterson, W. D., Jr. Problems and experience in the characterization of tissue culture cells. Rev. Biol. 41:124–130; 1966.
Stulberg, C. S.; Peterson, W. D.; Simpson, W. F. Identification of cells in culture. Am. J. Hematol. 1:237–242; 1976.
Stulberg, C. S.; Simpson, W. F.; Berman, L. Species related antigens of mammalian cell strains as detected by immunofluorescence. Proc. Soc. Exp. Biol. Med. 108:434–439; 1961a.
Stulberg, C. S.; Simpson, W. F.; Peterson, W. D., Jr., et al. Determination of species antigens of cultured cells by immunofluorescence. Fed. Proc. Fed. Am. Soc. Exp. Biol. 20:150; 1961b.
Thacker, J.; Webb, M.; Debenham, P. Fingerprinting cell lines: use of human hypervariable DNA probes to characterize mammalian cell cultures. Somatic Cell Mol. Genet. 14:519–525; 1988.
van Helden, P. D.; Wiid, I.; Albrecht, C. F., et al. Cross-contamination of human esophageal squamous carcinoma cell lines detected by DNA fingerprint analysis. Cancer Res. 48:5660–5662; 1988.
Vilien, M.; Christiansen, H.; Wolf, H., et al. Comparative studies of normal, “spontaneously transformed” and malignant human uroepithelial cells in vitro. Eur. J. Cancer & Clin. Oncol. 19:775–789; 1983.
Webb, M. B.; Debenham, P. G. Cell line characterization by DNA fingerprinting: a review. Dev. Biol. Stand. 76:39–42; 1992.
Westwood, L. C.; Macpherson, I.; Titmuss, D. H. J. Transplantation of normal cells in tissue culture, its significance relating to malignancy and in vitro vaccine production. Br. J. Exp. Pathol. 38:138; 1957.
World Health Organization Study Group (WHOSG). Cells, Products safety. Dev. Biol. Stand. 68:1–81; 1987.
Author information
Authors and Affiliations
Additional information
The article presents only a personal opinion of the coauthor.
Rights and permissions
About this article
Cite this article
Markovic, O., Markovic, N. Cell cross-contamination in cell cultures: The silent and neglected danger. In Vitro Cell.Dev.Biol.-Animal 34, 1–8 (1998). https://doi.org/10.1007/s11626-998-0040-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11626-998-0040-y